We have located links that may give you full text access.
JOURNAL ARTICLE
RESEARCH SUPPORT, NON-U.S. GOV'T
Simultaneous determination of oxiracetam and its degraded substance in rat plasma by HPLC-MS/MS and its application to pharmacokinetic study after a single high-dose intravenous administration.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences 2014 October 16
A simple, rapid and sensitive reversed-phase ultra-performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS) method was developed and validated for the simultaneous quantitative determination of oxiracetam and its degraded substance 4-hydroxy-2-oxo-1-pyrrolidine acetic acid (HOPAA) in rat plasma. After plasma samples were deproteinized with acetonitrile, the post-treatment samples were analyzed on a C18 column interfaced with a triple quadrupole tandem mass spectrometer in the positive electrospray ionization mode at a flow rate of 0.35ml/min. Piracetam was used as internal standard (IS). Multiple selected reaction monitoring was performed using the transitions m/z 159.00→141.94, 159.95→113.98 and 142.98→125.97 to quantify oxiracetam, HOPAA and IS, respectively. This method was validated over the concentration range of 25-2250μg/ml for oxiracetam (r(2)≥0.99) and 0.5-250μg/ml (r(2)≥0.99) for HOPAA. Intra-run and inter-run precision values of oxiracetam and HOPAA were less than 15% and accuracy was within 85-115% at all quality control levels. The average extraction recovery was 93.9% for oxiracetam and 95.6% for HOPAA, respectively. In conclusion, a simple, sensitive and specific HPLC-MS/MS method was successfully applied to the pharmacokinetic study in rats after an intravenous administration at a high dose of 2g/kg.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app